PDB Short entry for 1RHK HEADER HYDROLASE/HYDROLASE INHIBITOR 14-NOV-03 1RHK TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL- TITLE 2 KETONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P17 SUBUNIT; COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 6 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 7 EC: 3.4.22.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: P12 SUBUNIT; COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 14 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 15 EC: 3.4.22.-; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: ACETYL-ASP-GLU-VAL-FPR; COMPND 19 CHAIN: C; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: PROPYLBENZENE IS COVALENTLY BOUND TO THE C-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: CASP3, CPP32; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: THE INHIBITOR IS CHEMICALLY SYNTHESIZED. KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON REVDAT 7 20-SEP-23 1RHK 1 REMARK REVDAT 6 21-DEC-22 1RHK 1 SEQADV LINK REVDAT 5 11-OCT-17 1RHK 1 REMARK REVDAT 4 27-JUL-11 1RHK 1 HETATM LINK REMARK REVDAT 3 13-JUL-11 1RHK 1 VERSN REVDAT 2 24-FEB-09 1RHK 1 VERSN REVDAT 1 11-MAY-04 1RHK 0 JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS,C.BAYLY, JRNL AUTH 2 S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO,A.GIROUX,E.GRIMM,Y.HAN, JRNL AUTH 3 D.MCKAY,D.W.NICHOLSON,E.PETERSON,J.RENAUD,S.ROY, JRNL AUTH 4 N.THORNBERRY,R.ZAMBONI JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 INHIBITORS: A JRNL TITL 2 STRUCTURAL ANALYSIS. JRNL REF J.MED.CHEM. V. 47 2466 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15115390 JRNL DOI 10.1021/JM0305523 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 26033.700 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 77.8 REMARK 3 NUMBER OF REFLECTIONS : 7965 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 845 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 10270 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 40.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 601 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 11.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 76 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.039 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1914 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.19000 REMARK 3 B22 (A**2) : 2.33000 REMARK 3 B33 (A**2) : -5.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.050 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.820 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 12.99 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : PARAM.ICE REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TOP.ICE REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1RHK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020750. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-96 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : SAINT V. 4.050 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8371 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.6 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 33.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.38 REMARK 200 R MERGE FOR SHELL (I) : 0.36200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG-5000, 100 MM CITRATE, 10 MM REMARK 280 DTT, 3 MM NAN(3), PH 5.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.97000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.33000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.41000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.97000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.33000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.41000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.97000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.33000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.41000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.97000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.33000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 48.41000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE SECOND PART OF THE BIOLOGICAL REMARK 300 ASSEMBLY IS GENERATED BY THE REMARK 300 TWO-FOLD AXIS: 1-X, Y, -Z REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 69.94000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -78.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 69.94000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 69.94000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-ACETYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-N-[(1S)-1- REMARK 400 (CARBOXYMETHYL)-2-OXO-5-PHENYLPENTYL]-L-VALINAMIDE IS PEPTIDE-LIKE, REMARK 400 A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-N-[(1S)-1- REMARK 400 (CARBOXYMETHYL)-2-OXO-5-PHENYLPENTYL]-L-VALINAMIDE REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ILE A 147 REMARK 465 SER A 148 REMARK 465 LEU A 149 REMARK 465 THR A 296 REMARK 465 ASP A 297 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 VAL B 312 REMARK 465 ASP B 313 REMARK 465 ASP B 314 REMARK 465 ASP B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 CYS B 318 REMARK 465 HIS B 319 REMARK 465 HIS B 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 197 32.94 74.45 REMARK 500 SER A 236 -170.99 -179.49 REMARK 500 CYS A 270 76.10 -102.05 REMARK 500 ASP B 326 36.66 71.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACETYL-ASP-GLU-VAL REMARK 800 -FPR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 900 RELATED ID: 1RHJ RELATED DB: PDB REMARK 900 RELATED ID: 1RHM RELATED DB: PDB REMARK 900 RELATED ID: 1RHQ RELATED DB: PDB REMARK 900 RELATED ID: 1RHR RELATED DB: PDB REMARK 900 RELATED ID: 1RHU RELATED DB: PDB DBREF 1RHK A 145 297 UNP P42574 ICE3_HUMAN 29 175 DBREF 1RHK B 310 402 UNP P42574 ICE3_HUMAN 176 277 DBREF 1RHK C 501 505 PDB 1RHK 1RHK 501 505 SEQADV 1RHK GLU B 324 UNP P42574 ASP 190 VARIANT SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 C 5 ACE ASP GLU VAL FPR HET ACE C 501 3 HET FPR C 505 17 HETNAM ACE ACETYL GROUP HETNAM FPR (3S)-3-AMINO-4-OXO-7-PHENYLHEPTANOIC ACID FORMUL 3 ACE C2 H4 O FORMUL 3 FPR C13 H17 N O3 FORMUL 4 HOH *14(H2 O) HELIX 1 1 HIS A 174 GLY A 175C 5 5 HELIX 2 2 GLY A 181 ASN A 195 1 15 HELIX 3 3 THR A 207 GLU A 221 1 15 HELIX 4 4 LEU A 258 ASN A 263 1 6 HELIX 5 5 PHE A 264 ARG A 266 5 3 HELIX 6 6 TRP B 348 ALA B 361 1 14 HELIX 7 7 GLU B 365 PHE B 380 1 17 HELIX 8 8 ASP B 381E HIS B 381I 5 5 SHEET 1 A 6 GLU A 199 ASN A 204 0 SHEET 2 A 6 GLU A 162 ASN A 169 1 N ASN A 169 O LYS A 203 SHEET 3 A 6 ARG A 227 LEU A 235 1 O VAL A 233 N ILE A 166 SHEET 4 A 6 LYS A 278 GLN A 283 1 O GLN A 283 N LEU A 234 SHEET 5 A 6 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 6 A 6 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329 SHEET 1 B 3 GLY A 238 GLU A 239 0 SHEET 2 B 3 ILE A 242 GLY A 245 -1 O ILE A 242 N GLU A 239 SHEET 3 B 3 GLY A 254 ASP A 257 -1 O GLY A 254 N GLY A 245 SHEET 1 C 3 GLY B 346 SER B 347 0 SHEET 2 C 3 TRP B 340 ASN B 342 -1 N ASN B 342 O GLY B 346 SHEET 3 C 3 GLU C 503 VAL C 504 -1 O GLU C 503 N ARG B 341 LINK SG CYS A 285 C FPR C 505 1555 1555 1.78 LINK C ACE C 501 N ASP C 502 1555 1555 1.33 LINK C VAL C 504 N FPR C 505 1555 1555 1.34 SITE 1 AC1 15 SER A 175A ARG A 179 HIS A 237 GLY A 238 SITE 2 AC1 15 GLU A 239 PHE A 244 GLN A 283 CYS A 285 SITE 3 AC1 15 SER B 339 TRP B 340 ARG B 341 ASN B 342 SITE 4 AC1 15 SER B 343 SER B 381A PHE B 381B CRYST1 69.940 84.660 96.820 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014298 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011812 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010328 0.00000